XML 140 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
GAIN (LOSS) ON INVESTMENTS, NET
12 Months Ended
Dec. 31, 2011
GAIN (LOSS) ON INVESTMENTS, NET  
GAIN (LOSS) ON INVESTMENTS, NET

20.   GAIN (LOSS) ON INVESTMENTS, NET

  • The components of gain (loss) on investments, net for the years ended December 31, 2011, 2010 and 2009 were as follows:

   
  2011   2010   2009  
 

Loss on auction rate securities

  $   $ (5,552 ) $ (5,210 )
 

Gain on auction rate securities settlement

            22,000  
 

Gain on disposal of investments

    22,776         804  
                 
 

 

  $ 22,776   $ (5,552 ) $ 17,594  
                 
  • In March 2011, in connection with an offer to acquire Cephalon, Inc. ("Cephalon"), the Company had invested $60.0 million to acquire 1,034,908 shares of common stock of Cephalon, which represented 1.366% of the issued and outstanding common stock of Cephalon as of March 14, 2011. On May 2, 2011, Cephalon announced that it had agreed to be acquired by Teva Pharmaceutical Industries Inc. and, consequently, the Company disposed of its entire equity investment in Cephalon for net proceeds of $81.3 million, which resulted in a net realized gain of $21.3 million recognized in earnings in the second quarter of 2011.